A group of Coinbase stockholders has filed a lawsuit against the company’s leadership over an alleged yearslong scheme involving the insider trading of billions of dollars worth of company stock. https://t.co/iNz6NhBe31 ...

法律与规则是控价的"尚方宝剑"。品牌方需完善知识产权布局，提前注册商标、申请外观专利，将产品包装、宣传文案等纳入保护范 围。针对未授权低价商家，可依据《电子商务法》《商标法》等相关法律法规，向平台提交投诉材料。多数电商平台都设有知识产权保 护通道，品牌方通过提交商标权证明、授权协议等文件，可要求平台下架违规商品、关闭违规店铺。对于情节严重的商家，还可通过法 律诉讼追究其侵权责任，形成有力震慑。 沟通协商与政策引导同样不可或缺。对于部分有意向规范经营的未授权商家，品牌方可主动沟通，邀请其加入正规授权体系，明确价格 政策和合作权益，将"对立面"转化为"合作伙伴"。同时，品牌需向所有授权经销商重申价格纪律，建立奖惩机制：对严格遵守价格规定 的经销商给予流量扶持、返利倾斜；对擅自低价销售的经销商，采取减少供货、取消授权等处罚措施，引导经销商共同维护市场秩序。 控价工作并非一劳永逸，需建立长效监测机制。品牌方应利用技术工具实时监控全网价格动态，设置价格预警线，一旦发现低价违规信 息立即启动处理流程。此外，还需关注社交媒体、直播带货等新兴销售渠道，这些场景中的低价乱象往往更隐蔽，需针对性制定控价策 略。某美妆品牌通过"日 ...

Luigi Mangione has watched surveillance videos of the killing of UnitedHealthcare CEO Brian Thompson at a court appearance.Mangione has pleaded not guilty to state and federal murder charges over the killing of Mr Thompson. The state charges carry the possibility of life in prison, while federal prosecutors are seeking the death penalty. The 27-year-old's lawyers are seeking to bar evidence, including a 9mm handgun and a notebook in which prosecutors say he described his intent to "wack" a health insurance ...

Gunnison Copper Repays US$7.3 Million of Nebari Secured Debt, Fully Eliminating Non-Convertible Portion of Second ARCAMajor Deleveraging Milestone Achieved as Company Moves to Fully Eliminate Nebari DebtDecember 01, 2025 5:05 PM EST | Source: Gunnison Copper Corp.Phoenix, Arizona--(Newsfile Corp. - December 1, 2025) - Gunnison Copper Corp. (TSX: GCU) (OTCQB: GCUMF) (FSE: 3XS0) ("Gunnison" or the "Company") is pleased to announce that it has fully repaid the US$7.3 million non-convertible princ ...

安徽金岩高嶺土新材料股份有限公司 章程 （聯交所上市後適用） 二○二五年十二月 | 目錄 | | --- | | 第一章 | 總則 | | 1 | | --- | --- | --- | --- | | 第二章 | | 公司經營宗旨和經營範圍 | 2 | | 第三章 | 股份 | | 3 | | 第一節 | | 股份發行 | 3 | | 第二節 | | 股份增減和回購 | 4 | | 第三節 | | 股份轉讓 | 5 | | 第四章 | | 股東和股東會 | 7 | | 第一節 | | 股東 | 7 | | 第二節 | | 股東會的一般規定 | 10 | | 第三節 | | 股東會的召集 | 14 | | 第四節 | | 股東會的提案與通知 | 16 | | 第五節 | | 股東會的召開 | 18 | | 第六節 | | 股東會的表決和決議 | 22 | | 第五章 | 董事會 | | 27 | | 第一節 | | 董事 | 27 | | 第二節 | | 董事會 | 31 | | 第六章 | | 總經理及其他高級管理人員 | 36 | | 第七章 | 監事會 | | 38 | | 第一節 | | 監事 | 3 ...

Shelby Knowles / Bloomberg / Getty Images Close Key Takeaways Eli Lilly (LLY) said Monday that it's lowering the price of its popular weight-loss drug Zepbound, about a month after striking a deal with the Trump administration to lower drug costs. The company said the price for a once-a-month single vial purchased through its LillyDirect digital health care platform will go down $50 for the 2.5-, 7.5-, 10-, 12.5-, and 15-milligram doses, and $100 for the 5-milligram dose. The prices range from $299 for the ...

In a rare interview, an under-the-radar high-speed trader sketches out plans for aggressive growth and international expansion https://t.co/PPjuDvqHnd ...

樂摩科技服務股份有限公司 章程（草案） （H股發行上市後適用） 1 | 目錄 | | --- | | 第一章 | 總則 | 3 | | --- | --- | --- | | 第二章 | 經營宗旨和範圍 | 4 | | 第三章 | 股份 | 5 | | 第一節 | 股份發行 | 5 | | 第二節 | 股份增減和回購 | 7 | | 第三節 | 股份轉讓 | 9 | | 第四章 | 股東和股東會 | 10 | | 第一節 | 股東 | 10 | | 第二節 | 股東會的一般規定 | 14 | | 第三節 | 股東會的召集 | 17 | | 第四節 | 股東會的提案與通知 | 18 | | 第五節 | 股東會的召開 | 20 | | 第六節 | 股東會的表決和決議 | 24 | | 第五章 | 董事會 | 29 | | 第一節 | 董事 | 29 | | 第二節 | 董事會 | 33 | | 第六章 | 總經理及其他高級管理人員 | 42 | | 第七章 | 監事會 | 44 | | 第一節 | 監事 | 44 | | 第二節 | 監事會 | 44 | | 第八章 | 財務會計制度、利潤分配和審計 | 46 | ...

CALGARY, Alberta, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable December 30, 2025, to shareholders of record on December 15, 2025. The dividend is designated as an eligible dividend for Canadian income tax purposes. Dividend Reinvestment Plan ("DRIP")Petrus' DRIP enables eligible shareholders to reinvest all or part of their cash dividend ...

TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life sciences company focused on pharmaceutical therapies, diagnostic products, and natural ingredients solutions, today announced that its wholly-owned subsidiary, Aeterna Zentaris GmbH, has entered into an exclusive distribution agreement with Wuzhou Drug International Trading Limited (“Wuzhou”) for the commercialization of Macrilen® (macimorelin) in Hong Kong, Macao, Sin ...